Another thing to remember is that cardiocel is steadily becoming the main source of revenue for Admedus. In the HY ending Dec 2014 cardiocel only accounted for 21% of AHZ revenue. By HY ending Dec 2015 that had grown to 35% (ie. $2.3 million out of $6.5 million).
Soon cardiocel will produce more than 50% of AHZ revenue. So future cardiocel growth will have a more direct impact on quarterly revenue than we've seen in the past.
- Forums
- ASX - By Stock
- Ann: CORONEO Australia New Zealand Distribution Partnership-AHZ.AX
Another thing to remember is that cardiocel is steadily becoming...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$11.43 |
Change
-0.120(1.04%) |
Mkt cap ! $241.6M |
Open | High | Low | Value | Volume |
$11.58 | $11.58 | $11.17 | $196.0K | 17.23K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 30 | $11.40 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$11.50 | 200 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 30 | 11.400 |
1 | 500 | 11.300 |
2 | 1711 | 11.250 |
1 | 2000 | 11.150 |
1 | 471 | 11.140 |
Price($) | Vol. | No. |
---|---|---|
11.500 | 200 | 1 |
11.800 | 4634 | 1 |
11.830 | 500 | 1 |
11.850 | 164 | 1 |
11.900 | 1000 | 1 |
Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
SPONSORED BY The Market Online